Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

CALGB 30801 A RANDOMIZED PHASE III DOUBLE BLIND TRIAL EVALUATING SELECTIVE COX-2 INHIBITION IN COX-2 EXPRESSING ADVANCED NON-SMALL CELL LUNG CANCER


Collapse Overview 
Collapse sponsor award id
CALGB 30801


Collapse Biography 

Collapse Time 
Collapse start date
2011-12-21